Ischemia Modified Albumin: A novel biomarker for the detection of cardiac ischemia

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 4, 2009, Pages 333-341

  Gaze, David C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Albumin; Albumin cobalt binding assay; Biomarker; Cardiac ischemia; Clinical study; Ischemia; Ischemia Modified Albumin; Oxidative stress

Indexed keywords

ALBUMIN; ISCHEMIA MODIFIED ALBUMIN; TROPONIN T;

ALBUMIN BLOOD LEVEL; AMINO TERMINAL SEQUENCE; CONFERENCE PAPER; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HUMAN; OXIDATIVE STRESS; PREDICTION; SENSITIVITY AND SPECIFICITY;

EID: 70350448857     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.333     Document Type: Conference Paper

References (70)

1. Apple, F. S., Wu, A. H., Mair, J., Ravkilde, J., Panteghini, M., Tate, J., Pagani, F., Christenson, R. H., Mockel, M., Danne, O. and Jaffe, A. S.: Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem., 51(5): 810-824 (2005).
2. Sadler, P. J., Tucker, A. and Viles, J. H.: Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+. Eur. J. Biochem., 220(1): 193-200 (1994).
3. Chan, B., Dodsworth, N., Woodrow, J., Tucker, A. and Harris, R.: Site-specific N-terminal auto-degradation of human serum albumin. Eur. J. Biochem., 227(1-2): 524-528 (1995).
4. McCord, J. M.: Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med., 312(3): 159-163 (1985).
5. Levine, R. L.: Ischemia: from acidosis to oxidation. FASEB J., 7(13): 1242-1246 (1993).
6. Cobbe, S. M. and Poole-Wilson, P. A.: The time of onset and severity of acidosis in myocardial ischaemia. J. Mol. Cell Cardiol., 12(8): 745-760 (1980).
7. Berenshtein, E., Mayer, B., Goldberg, C., Kitrossky, N. and Chevion, M.: Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J. Mol. Cell Cardiol., 29(11): 3025-3034 (1997).
8. Chevion, M., Jiang, Y., Har-El, R., Berenshtein, E., Uretzky, G. and Kitrossky, N.: Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc. Natl. Acad. Sci. U.S.A., 90(3): 1102-1106 (1993).
9. Bar-Or, D., Lau, E. and Winkler, J. V.: A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J. Emerg. Med., 19(4): 311-315 (2000).
10. Bar-Or, D., Winkler, J. V., Vanbenthuysen, K., Harris, L., Lau, E. and Hetzel, F. W.: Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am. Heart J., 141(6): 985-991 (2001).
11. Bar-Or, D., Curtis, G., Rao, N., Bampos, N. and Lau, E.: Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur. J. Biochem., 268(1): 42-47 (2001).
12. Marx, G. and Chevion, M.: Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. Biochem. J., 236(2): 397-400 (1986).
13. Bhagavan, N. V., M.Lai, E., Rios, P. A., Yang, J., Ortega-Lopez, A. M., Shinoda, H., Honda, S. A., Rios, C. N., Sugiyama, C. E. and Ha, C. E.: Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin. Chem., 49(4): 581-585 (2003).
14. Mothes, E. and Faller, P.: Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry, 46(8): 2267-2274 (2007).
15. Senes, M., Kazan, N., Coskun, O., Zengi, O., Inan, L. and Yucel, D.: Oxidative and nitrosative stress in acute ischaemic stroke. Ann. Clin. Biochem., 44(Pt 1): 43-47 (2007).
16. Sinha, M. K., Vazquez, J. M., Calvino, R., Gaze, D. C., Collinson, P. O. and Kaski, J. C.: Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction. Heart, 92(12): 1852-1853 (2006).
17. Borderie, D., Allanore, Y., Meune, C., Devaux, J. Y., Ekindjian, O. G. and Kahan, A.: High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin. Chem., 50(11): 2190-2193 (2004).
18. Roy, D., Quiles, J., Gaze, D. C., Collinson, P., Kaski, J. C. and Baxter, G. F.: Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 92(1): 113-114 (2006).
19. Quiles, J., Roy, D., Gaze, D., Garrido, I. P., Avanzas, P., Sinha, M. and Kaski, J. C.: Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am. J. Cardiol., 92(3): 322-324 (2003).
20. Garrido, I. P., Roy, D., Calvino, R., Vazquez-Rodriguez, J. M., Aldama, G., Cosin-Sales, J., Quiles, J., Gaze, D. C. and Kaski, J. C.: Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am. J. Cardiol., 93(1): 88-90 (2004).
21. Dusek, J., St'asek, J., Tichy, M., Bis, J., Gregor, J., Vojacek, J., Masin, V., Polansky, P., Brtko, M. and Cernohorsky, D.: Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clin. Chim. Acta, 367(1-2): 77-80 (2006).
22. Cho, D. K., Choi, J. O., Kim, S. H., Choi, J., Rhee, I., Ki, C. S., Lee, S. C. and Gwon, H. C.: Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron. Artery Dis., 18(2): 83-87 (2007).
23. Roy, D., Quiles, J., Sinha, M., Aldama, G., Gaze, D. and Kaski, J. C.: Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am. J. Cardiol., 93(3): 366-368 (2004).
24. Roy, D., Quiles, J., Sinha, M., Floros, D., Gaze, D., Collinson, P., Baxter, G. F. and Kaski, J. C.: Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am. J. Cardiol., 94(2): 234-236 (2004).
25. Sbarouni, E., Georgiadou, P., Panagiotakos, D., Livanis, E. G., Theodorakis, G. N. and Kremastinos, D. T.: Ischaemia modified albumin in radiofrequency catheter ablation. Europace., 9(2): 127-129 (2007).
26. Wu, A. H., Morris, D. L., Fletcher, D. R., Apple, F. S., Christenson, R. H. and Painter, P. C.: Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc. Toxicol., 1(2): 147-151 (2001).
27. Christenson, R. H., Duh, S. H., Sanhai, W. R., Wu, A. H., Holtman, V., Painter, P., Branham, E., Apple, F. S., Murakami, M. and Morris, D. L.: Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin. Chem., 47(3): 464-470 (2001).
28. Sinha, M. K., Roy, D., Gaze, D. C., Collinson, P. O. and Kaski, J. C.: Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg. Med. J., 21(1): 29-34 (2004).
29. Consuegra-Sanchez, L., Bouzas-Mosquera, A., Sinha, M. K., Collinson, P. O., Gaze, D. C. and Kaski, J. C.: Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels, 23(3): 174-180 (2008).
30. Collinson, P. O., Gaze, D. C., Bainbridge, K., Morris, F., Morris, B., Price, A. and Goodacre, S.: Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg. Med. J., 23(4): 256-261 (2006).
31. Abadie, J. M., Blassingame, C. L. and Bankson, D. D.: Albumin cobalt binding assay to rule out acute coronary syndrome. Ann. Clin. Lab Sci., 35(1): 66-72 (2005).
32. Keating, L., Benger, J. R., Beetham, R., Bateman, S., Veysey, S., Kendall, J. and Pullinger, R.: The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg. Med. J., 23(10): 764-768 (2006).
33. Worster, A., Devereaux, P. J., Heels-Ansdell, D., Guyatt, G. H., Opie, J. Mookadam, F. and Hill, S. A.: Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ., 172(13): 1685-1690 (2005).
34. Aparci, M., Kardesoglu, E., Ozmen, N., Ozcan, O., Cebeci, B. S., Cingozbay, B. Y. and Dincturk, M.: Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome. Coron. Artery Dis., 18(5): 367-373 (2007).
35. Peacock, F., Morris, D. L., Anwaruddin, S., Christenson, R. H., Collinson, P. O., Goodacre, S. W., Januzzi, J. L., Jesse, R. L., Kaski, J. C., Kontos, M. C., Lefevre, G., Mutrie, D., Sinha, M. K., Uettwiller-Geiger, D. and Pollack, C. V.: Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am. Heart J., 152(2): 253-262 (2006).
36. Gaze, D. C., Crompton, L. and Collinson, P. O.: Stability of Ischemia Modified Albumin (IMA) as assessed by the Albumin Cobalt Binding (ACB™) test. Clin. Chem., 49, A40 (2009).
37. Beetham, R., Monk, C., Keating, L., Benger, J. R. and Kendall, J.: Effects of storage at -20 degrees C on ischaemia-modified albumin results. Ann. Clin. Biochem., 43(Pt 6): 500-502 (2006).
38. Maguire, O. C., O'Sullivan, J., Ryan, J. and Cunningham, S. K.: Evaluation of the albumin cobalt binding (ACB) assay for measurement of ischaemia-modified albumin (IMA) on the Beckman Coulter LX-20. Ann. Clin. Biochem., 43(Pt 6): 494-499 (2006).
39. Govender, R., De Greef, J., Delport, R., Becker, P. J. and Vermaak, W. J.: Biological variation of ischaemia-modified albumin in healthy subjects. Cardiovasc. J. Afr., 19(3): 141-144 (2008).
40. Gaze, D. C., Crompton, L. and Collinson, P.: Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations. Med. Princ. Pract., 15(4): 322-324 (2006).
41. Lee, Y.W., Kim, H. J., Cho, Y. H., Shin, H. B., Choi, T. Y. and Lee, Y. K.: Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin. Chim. Acta, 384(1-2): 24-27 (2007).
42. van der Zee, P. M., Verberne, H. J., van Straalen, J. P., Sanders, G. T., Eck-Smit, B. L., de Winter, R. J. and Fischer, J. C.: Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin. Chem., 51(9): 1744-1746 (2005).
43. Apple, F. S., Quist, H. E., Otto, A. P., Mathews, W. E. and Murakami, M. M.: Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin. Chem., 48(7): 1097-1100 (2002).
44. Lippi, G., Brocco, G., Salvagno, G. L., Montagnana, M., Dima, F. and Guidi, G. C.: High-workload endurance training may increase serum ischemia-modified albumin concentrations. Clin. Chem. Lab Med., 43(7): 741-744 (2005).
45. Lippi, G., Salvagno, G. L., Montagnana, M., Schena, F., Ballestrieri, F. and Guidi, G. C.: Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin. Clin. Chim. Acta, 367(1-2): 175-180 (2006).
46. Middleton, N., Shave, R., George, K.,Whyte, G., Forster, J., Oxborough, D., Gaze, D. and Collinson, P.: Novel application of flow propagation velocity and ischaemia-modified albumin in analysis of postexercise cardiac function in man. Exp. Physiol, 91(3): 511-519 (2006).
47. Zapico-Muniz, E., Santalo-Bel, M., Merce-Muntanola, J., Montiel, J. A., Martinez-Rubio, A. and Ordonez-Llanos, J.: Ischemia-modified albumin during skeletal muscle ischemia. Clin. Chem., 50(6): 1063-1065 (2004).
48. Falkensammer, J., Stojakovic, T., Huber, K., Hammerer-Lercher, A., Gruber, I., Scharnagl, H., Fraedrich, G., Santner, W., Schocke, M. and Greiner, A.: Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin. Chem. Lab Med., 45(4): 535-540 (2007).
49. Refaai, M. A., Wright, R. W., Parvin, C. A., Gronowski, A. M., Scott, M. G. and Eby, C. S.: Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin. Chim. Acta, 366(1-2): 264-268 (2006).
50. Roy, D., Quiles, J., Sharma, R., Sinha, M., Avanzas, P., Gaze, D. and Kaski, J. C.: Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin. Chem., 50(9): 1656-1660 (2004).
51. Hacker, M., Hoyer, H. X., la Fougere, C., Akcakoyunlu, E., Schuhmann, C., Forster, S., Weber, C., Reincke, M., Tiling, R. and Sohn, H. Y.: Effects of peripheral vascular intervention on ischemia-modified albumin. Coron. Artery Dis., 18(5): 375-379 (2007).
52. Sbarouni, E., Georgiadou, P., Theodorakis, G. N. and Kremastinos, D.,T.: Ischemia-modified albumin in relation to exercise stress testing. J. Am. Coll. Cardiol., 48(12): 2482-2484 (2006).
53. Troxler, M., Thompson, D. and Homer-Vanniasinkam, S.: Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur. J. Vasc. Endovasc. Surg., 31(2): 164-169 (2006).
54. Banu, N. S., Gaze, D. C., Bruce, H., Collinson, P. O., Belli, A. M. and Manyonda, I. T.: Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroids. Am. J. Obstet. Gynecol., 196(3): 213-215 (2007).
55. Kalay, N., Cetinkaya, Y., Basar, E., Muhtaroglu, S., Ozdogru, I., Gul, A., Eryol, N. K., Oguzhan, A. and Abaci, A.: Use of ischemia-modified albumin in diagnosis of coronary artery disease. Coron. Artery Dis., 18(8): 633-637 (2007).
56. Kurz, K., Voelker, R., Zdunek, D., Wergeland, R., Hess, G., Ivandic, B., Katus, H. and Giannitsis, E.: Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin. Res. Cardiol., 96(3): 152-159 (2007).
57. Abboud, H., Labreuche, J., Meseguer, E., Lavallee, P. C., Simon, O., Olivot, J. M., Mazighi, M., Dehoux, M., Benessiano, J., Steg, P. G. and Amarenco, P.: Ischemia-modified albumin in acute stroke. Cerebrovasc. Dis., 23(2-3): 216-220 (2007).
58. Talwalkar, S. S., Bon-Homme, M., Miller, J. J. and Elin, R. J.: Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann. Clin. Lab Sci., 38(2): 132-137 (2008).
59. Turedi, S., Gunduz, A., Mentese, A., Karahan, S. C., Yilmaz, S. E., Eroglu, O., Nuhoglu, I., Turan, I. and Topbas, M.: Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am. J. Emerg. Med., 25(7): 770-773 (2007).
60. Turedi, S., Gunduz, A.,Mentese, A., Topbas, M., Karahan, S. C., Yeniocak, S., Turan, I., Eroglu, O., Ucar, U., Karaca, Y., Turkmen, S. and Russell, R. M.: The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir. Res., 9: 49 (2008).
61. Sharma, R., Gaze, D. C., Pellerin, D., Mehta, R. L., Gregson, H., Streather, C. P., Collinson, P. O. and Brecker, S. J.: Ischemia-modified albumin predicts mortality in ESRD. Am. J. Kidney Dis., 47(3): 493-502 (2006).
62. Sharma, R., Gaze, D. C., Pellerin, D., Mehta, R. L., Gregson, H., Streather, C. P., Collinson, P. O. and Brecker, S. J.: Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease. Clin. Sci. (Lond), 113(1): 25-32 (2007).
63. Cichota, L. C., Moresco, R. N., Duarte, M. M. and da Silva, J. E.: Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J. Clin. Lab Anal., 22(1): 1-5 (2008).
64. Montagnana, M., Lippi, G., Fava, C., Minuz, P., Santonastaso, C. L., Arosio, E. and Guidi, G. C.: Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease. Clin. Chem. Lab Med., 44(2): 207-212 (2006).
65. Kumar, A., Sivakanesan, R. and Gunasekera, S.: Ischemia Modified Albumin: A potent marker in acute myocardial infarction in normolipidaemic. Pak. J. Med. Sci., 24(3): 364-367 (2009).
66. Piwowar, A., Knapik-Kordecka, M. and Warwas, M.: Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis. Markers, 24(6): 311-317 (2008).
67. Knapik-Kordecka, M., Piwowar, A., Zurawska-Plaksej, E. and Warwas, M.: [Ischemia modified albumin - specific marker in cardiological diagnostics?]. Wiad. Lek., 61(10-12): 263-268 (2008).
68. Gugliucci, A., Hermo, R., Monroy, C., Numaguchi, M. and Kimura, S.: Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin. Chim. Acta, 362(1-2): 155-160 (2005).
69. Prefumo, F., Gaze, D. C., Papageorghiou, A. T., Collinson, P. O. and Thilaganathan, B.: First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum. Reprod., 22(7): 2029-2032 (2007).
70. Collinson, P. O. and Stubbs, P. J.: Are troponins confusing? Heart, 89(11): 1285-1287 (2003).